Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Expression of CD109 in human cancer

Abstract

It was recently reported that the human CD109 gene encodes a glycosyl-phosphatidylinositol-anchored glycoprotein that is a member of the α2-macroglobulin/C3, C4, C5 family of thioester-containing proteins. In this study, we found that the expression of mouse CD109 gene was upregulated in NIH3T3 cells expressing RET tyrosine kinase with a multiple endocrine neoplasia 2B mutation. Northern blot analysis showed a high level of expression of the CD109 gene only in the testis in normal human and mouse tissues. In addition, its expression was high in some human tumor cell lines, which included squamous cell carcinoma and glioblastoma cell lines, whereas it was undetectable in neuroblastoma and small-cell lung carcinoma cell lines. When CD109 expression was examined in 33 cases of human lung cell carcinomas by quantitative RT–PCR, a significant high expression of CD109 was detected in about half of squamous cell carcinomas examined, but not in adenocarcinoma, large-cell carcinoma and small-cell carcinoma. Similarly, upregulation of CD109 was observed in nine out of 17 esophageal squamous cell carcinomas. Thus, these results suggested that CD109 might be a useful molecular target for the development of new therapeutics for malignant tumors, such as squamous cell carcinoma.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Haregewoin A, Solomon K, Hom RC, Soman G, Bergelson JM, Bhan AK and Finberg RW . (1994). Cell. Immunol., 156, 357–370.

  • Hofmann K, Bucher P, Falquet L and Bairoch A . (1999). Nucleic Acids Res., 27, 215–219.

  • Lin M, Sutherland DR, Horsfall W, Totty N, Yeo E, Nayar R, Wu X-F and Schuh AC . (2002). Blood, 99, 1683–1691.

  • Murray LJ, Bruno E, Uchida N, Hoffman R, Nayar R, Yeo EL, Schuh AC and Sutherland DR . (1999). Exp. Hematol., 27, 1282–1294.

  • Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L and Buhring HJ . (1997). Blood, 90, 111–125.

  • Smith JW, Hayward CP, Horsewood P, Warkentin TE, Denomme GA and Kelton JG . (1995). Blood, 86, 2807–2814.

  • Solomon KR, Mallory MA and Finberg RW . (1998). Biochem. J., 334, 325–333.

  • Sutherland DR and Yeo E . (1995). CDw109 Cluster Report: Leukocyte Typing V, Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF and Todd RF (eds). Oxford University Press: Oxford, pp. 1767–1769.

    Google Scholar 

  • Sutherland DR and Yeo E . (1998). CD109 Workshop Panel Report: Leukocyte Typing VI, Kishimoto T, Kikutani H, von dem Borne AEGKr., Goyert SM, Mason DY, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sugamura K, Zola H (eds). Garland Publishing: London, pp. 714–716.

    Google Scholar 

  • Sutherland DR, Yeo E, Ryan A, Mills GB, Bailey D and Baker MA . (1991). Blood, 77, 84–93.

  • Takahashi M . (2001). Cytokine Growth Factor Rev., 12, 361–373.

  • Watanabe T, Ichihara M, Hashimoto M, Shimono K, Shimoyama Y, Nagasaka T, Murakumo Y, Murakami H, Sugiura H, Iwata H, Ishiguro N and Takahashi M . (2002). Am. J. Pathol., 161, 249–256.

  • Yeo EL and Sutherland DR . (1992). Blood, 80, 56.

Download references

Acknowledgements

This work was supported in part by Grants-in-Aid for COE (Center of Excellence) Research, Scientific Research and Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank K Imaizumi and K Uchiyama for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahide Takahashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hashimoto, M., Ichihara, M., Watanabe, T. et al. Expression of CD109 in human cancer. Oncogene 23, 3716–3720 (2004). https://doi.org/10.1038/sj.onc.1207418

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207418

Keywords

This article is cited by

Search

Quick links